Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Glomerulonephritis”

75 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 75 results

Early research (Phase 1)Study completedNCT02693366
What this trial is testing

Stem Cell Therapy for Patients With Focal Segmental Glomerulosclerosis

Who this might be right for
Focal Segmental GlomerulosclerosisChronic Kidney Diseases
Universidade Federal do Rio de Janeiro 5
Post-approval studies (Phase 4)Looking for participantsNCT06712407
What this trial is testing

Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy

Who this might be right for
IgA Nephropathy
Calliditas Therapeutics AB 60
Not applicableStudy completedNCT01156428
What this trial is testing

Inflammatory and Immune Profiling of Kidney Tissue Obtained From Patients With Newly Diagnosed Kidney Disease

Who this might be right for
ProteinuriaKidney InjuryChronic Kidney Disease
The Rogosin Institute 119
Testing effectiveness (Phase 2)UnknownNCT02682459
What this trial is testing

ACE-inhibitors in Extracapillary Glomerulonephritis

Who this might be right for
Extracapillary Glomerulonephritis
Monia Lorini 22
Large-scale testing (Phase 3)Active Not RecruitingNCT04557462
What this trial is testing

A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

Who this might be right for
Primary IgA Nephropathy
Novartis Pharmaceuticals 448
Testing effectiveness (Phase 2)Study completedNCT05834738
What this trial is testing

Randomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects With IgA Nephropathy

Who this might be right for
IgA NephropathyImmunoglobulin A Nephropathy
Novartis Pharmaceuticals 54
Post-approval studies (Phase 4)Study completedNCT00863252
What this trial is testing

Mycophenolate Mofetil for IgA Nephropathy

Who this might be right for
IGA Nephropathy
The University of Hong Kong 40
Testing effectiveness (Phase 2)Study completedNCT05237388
What this trial is testing

Janus Kinase-STAT Inhibition to Reduce APOL1 Associated Kidney Disease

Who this might be right for
Chronic Kidney Diseases
Duke University 8
Large-scale testing (Phase 3)UnknownNCT04654507
What this trial is testing

Efficacy of Corticosteroids in Reducing Renal Scarring in Acute Pyelonephritis in Children

Who this might be right for
Urinary Tract Infections in ChildrenDexamethasoneKidney Scarring+4 more
Hamad Medical Corporation 120
Not applicableActive Not RecruitingNCT02194582
What this trial is testing

Genetic Causes of FSGS, Nephrotic Syndrome, or Kidney Failure

Who this might be right for
Focal Segmental GlomerulosclerosisNephrotic SyndromeEnd Stage Renal Disease+2 more
Beth Israel Deaconess Medical Center 2,050
Post-approval studies (Phase 4)UnknownNCT04020328
What this trial is testing

Leflunomide Plus Low Dose Corticosteroid in Immunoglobulin A (IgA) Nephropathy With Renal Insufficiency

Who this might be right for
Glomerulonephritis, IGARenal Insufficiency, Chronic
Shenzhen Second People's Hospital 70
Testing effectiveness (Phase 2)Study completedNCT00001457
What this trial is testing

Lamivudine for Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis BChronic Hepatitis DGlomerulonephritis+1 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 60
Not applicableLooking for participantsNCT06682507
What this trial is testing

High Quality Evidence of Guangzhou Lupus Nephritis Cohort (HOPE Cohort)

Who this might be right for
Lupus Nephritis (LN)
First Affiliated Hospital, Sun Yat-Sen University 5,000
Early research (Phase 1)Study completedNCT06922305
What this trial is testing

Relative Bioavailability Study of HR19042 in Healthy Subjects

Who this might be right for
Primary IgA Nephropathy; Autoimmune Hepatitis
Jiangsu HengRui Medicine Co., Ltd. 18
Post-approval studies (Phase 4)Study completedNCT00755859
What this trial is testing

"Steroids and Azathioprine Versus Steroids Alone in IgAN"

Who this might be right for
IGA Nephropathy
A. Manzoni Hospital 206
Not applicableStudy completedNCT01931644
What this trial is testing

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

Who this might be right for
All Diagnosed Health ConditionsADD/ADHDAlopecia Areata+58 more
Sanguine Biosciences 17,667
Not applicableStudy completedNCT01370200
What this trial is testing

Regional Citrate Anticoagulation in Plasma Exchange Treatment

Who this might be right for
Focal Segmental GlomerulosclerosisGuillain-Barre Syndrome
University Medical Centre Ljubljana 140
Testing effectiveness (Phase 2)Study completedNCT00446459
What this trial is testing

Effects of Mycophenolate Mofetil (MMF) On Anti-HLA (Human Leukocyte Antigen)Antibody Levels In Patients Awaiting Cadaveric Renal Transplant.

Who this might be right for
Kidney Failure, ChronicDiabetic NephropathiesGlomerulonephritis, IGA+1 more
University of Washington 45
Not applicableLooking for participantsNCT01802034
What this trial is testing

Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)

Who this might be right for
Kidney DiseasesKidney Failure, ChronicDiabetic Nephropathy+2 more
The Rogosin Institute 2,000
Post-approval studies (Phase 4)Looking for participantsNCT06676384
What this trial is testing

Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (≥18 Years) Primary IgA Nephropathy?

Who this might be right for
IgA NephropathyRenal Insufficiency, ChronicIgA Vasculitis+1 more
Christian Medical College, Vellore, India 585
Next Page